Literature DB >> 31597020

Controlled Trial of Two Incremental Milk-Feeding Rates in Preterm Infants.

Jon Dorling1, Jane Abbott1, Janet Berrington1, Beth Bosiak1, Ursula Bowler1, Elaine Boyle1, Nicholas Embleton1, Oliver Hewer1, Samantha Johnson1, Edmund Juszczak1, Alison Leaf1, Louise Linsell1, Kenny McCormick1, William McGuire1, Omar Omar1, Christopher Partlett1, Mehali Patel1, Tracy Roberts1, Ben Stenson1, John Townend1.   

Abstract

BACKGROUND: Observational data have shown that slow advancement of enteral feeding volumes in preterm infants is associated with a reduced risk of necrotizing enterocolitis but an increased risk of late-onset sepsis. However, data from randomized trials are limited.
METHODS: We randomly assigned very preterm or very-low-birth-weight infants to daily milk increments of 30 ml per kilogram of body weight (faster increment) or 18 ml per kilogram (slower increment) until reaching full feeding volumes. The primary outcome was survival without moderate or severe neurodevelopmental disability at 24 months. Secondary outcomes included components of the primary outcome, confirmed or suspected late-onset sepsis, necrotizing enterocolitis, and cerebral palsy.
RESULTS: Among 2804 infants who underwent randomization, the primary outcome could be assessed in 1224 (87.4%) assigned to the faster increment and 1246 (88.7%) assigned to the slower increment. Survival without moderate or severe neurodevelopmental disability at 24 months occurred in 802 of 1224 infants (65.5%) assigned to the faster increment and 848 of 1246 (68.1%) assigned to the slower increment (adjusted risk ratio, 0.96; 95% confidence interval [CI], 0.92 to 1.01; P = 0.16). Late-onset sepsis occurred in 414 of 1389 infants (29.8%) in the faster-increment group and 434 of 1397 (31.1%) in the slower-increment group (adjusted risk ratio, 0.96; 95% CI, 0.86 to 1.07). Necrotizing enterocolitis occurred in 70 of 1394 infants (5.0%) in the faster-increment group and 78 of 1399 (5.6%) in the slower-increment group (adjusted risk ratio, 0.88; 95% CI, 0.68 to 1.16).
CONCLUSIONS: There was no significant difference in survival without moderate or severe neurodevelopmental disability at 24 months in very preterm or very-low-birth-weight infants with a strategy of advancing milk feeding volumes in daily increments of 30 ml per kilogram as compared with 18 ml per kilogram. (Funded by the Health Technology Assessment Programme of the National Institute for Health Research; SIFT Current Controlled Trials number, ISRCTN76463425.).
Copyright © 2019 Massachusetts Medical Society.

Entities:  

Mesh:

Year:  2019        PMID: 31597020     DOI: 10.1056/NEJMoa1816654

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  19 in total

1.  Routine gastric residual volume measurement to guide enteral feeding in mechanically ventilated infants and children: the GASTRIC feasibility study.

Authors:  Lyvonne N Tume; Kerry Woolfall; Barbara Arch; Louise Roper; Elizabeth Deja; Ashley P Jones; Lynne Latten; Nazima Pathan; Helen Eccleson; Helen Hickey; Roger Parslow; Jennifer Preston; Anne Beissel; Izabela Andrzejewska; Chris Gale; Frederic V Valla; Jon Dorling
Journal:  Health Technol Assess       Date:  2020-05       Impact factor: 4.014

Review 2.  Macrolides for the prevention and treatment of feeding intolerance in preterm low birth weight infants: a systematic review and meta-analysis.

Authors:  Sriparna Basu; Susan Smith
Journal:  Eur J Pediatr       Date:  2020-10-12       Impact factor: 3.183

3.  [Clinical guidelines for the diagnosis and treatment of neonatal necrotizing enterocolitis (2020)].

Authors: 
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-01

4.  Impact of Early Fortification in Very Low Birth Weight Infants on the Incidence of Malnutrition During a Trophamine Shortage.

Authors:  Brianna Hemmann; Justin Josephsen; Noah Hillman; Rita Chrivia; Paula Buchanan; Howard Williams; Nikki Burleyson
Journal:  J Pediatr Pharmacol Ther       Date:  2022-03-21

5.  Postnatal Serum Total Thyroxine Level Associated with Short- and Long-Term Anthropometric Outcomes in Very Preterm Infants.

Authors:  Yen-Ju Chen; Wei-Ying Chu; Yu-Wen Pan; Chen-Yueh Wang; Yen-Yin Chou; Chyi-Her Lin; Kennosuke Tsuda; Osuke Iwata; Wen-Hao Yu; Yung-Chieh Lin
Journal:  Nutrients       Date:  2022-05-14       Impact factor: 6.706

6.  Two speeds of increasing milk feeds for very preterm or very low-birthweight infants: the SIFT RCT.

Authors:  Jon Dorling; Oliver Hewer; Madeleine Hurd; Vasha Bari; Beth Bosiak; Ursula Bowler; Andrew King; Louise Linsell; David Murray; Omar Omar; Christopher Partlett; Catherine Rounding; John Townend; Jane Abbott; Janet Berrington; Elaine Boyle; Nicholas Embleton; Samantha Johnson; Alison Leaf; Kenny McCormick; William McGuire; Mehali Patel; Tracy Roberts; Ben Stenson; Warda Tahir; Mark Monahan; Judy Richards; Judith Rankin; Edmund Juszczak
Journal:  Health Technol Assess       Date:  2020-04       Impact factor: 4.014

7.  Management of Respiratory Distress Syndrome in Preterm Infants In Wales: A Full Audit Cycle of a Quality Improvement Project.

Authors:  Christopher Course; Mallinath Chakraborty
Journal:  Sci Rep       Date:  2020-02-26       Impact factor: 4.379

8.  Concentrated Preterm Formula as a Liquid Human Milk Fortifier at Initiation Stage in Extremely Low Birth Weight Preterm Infants: Short Term and 2-year Follow-up Outcomes.

Authors:  Yung-Chieh Lin; Yen-Ju Chen; Chao-Ching Huang; Chi-Chang Shieh
Journal:  Nutrients       Date:  2020-07-26       Impact factor: 5.717

Review 9.  Preterm birth and sustained inflammation: consequences for the neonate.

Authors:  Alexander Humberg; Ingmar Fortmann; Bastian Siller; Matthias Volkmar Kopp; Egbert Herting; Wolfgang Göpel; Christoph Härtel
Journal:  Semin Immunopathol       Date:  2020-07-13       Impact factor: 9.623

Review 10.  Nutrition in Necrotizing Enterocolitis and Following Intestinal Resection.

Authors:  Jocelyn Ou; Cathleen M Courtney; Allie E Steinberger; Maria E Tecos; Brad W Warner
Journal:  Nutrients       Date:  2020-02-18       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.